The Ethismos team of scientists and researchers is hard at work on preclinical research programs to develop medications and therapies to address substance abuse disorders including alcohol use disorder (AUD) and stimulants (cocaine/methamphetamine/amphetamine-type stimulants).

The data we’ve gathered in our preclinical programs is very promising and has great potential help people with various SUDs - and we are committed to advancing this science and research . Ethismos is preparing to advance several of these preclinical projects to FDA phase 2 clinical trials in the near future.